• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Search Orphan Drug Designations and Approvals

  • Print
  • Share
  • E-mail
Generic Name:  18-(p-[131I]-iodophenyl)octadecyl phosphocholine
Date Designated:  07/03/2018
Orphan Designation:  Treatment of Ewing’s Sarcoma
Orphan Designation Status:  Designated
FDA Orphan Approval Status:  Not FDA Approved for Orphan Indication
Cellectar Biosciences, Inc.
3301 Agriculture Drive
Madison, Wisconsin 53716
United States

The sponsor address listed is the last reported by the sponsor to OOPD.
*Exclusivity Protected Indications are shown for approvals from Jan. 1, 2013, to the present.